US20230159508A1

Inhibitors of receptor interacting protein kinase i for the treatment of …

University of Texas System

Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Richard T. Lewis
Priority date: February 28, 2020
Filing date: August 17, 2022
Publication date: May 25, 2023
Language: en
PDF source: https://patentimages.storage.googleapis.com/37/6e/d7/1d800792688c4a/US20230159508A1.pdf
Metadata fetched: August 29, 2026 00:30